siRNA Related Product

SKU
SR30002
Trilencer-27 Fluorescent-labeled transfection control siRNA duplex - 1 nmol
  $142.00
In Stock*
Specifications
Specifications
Product Data
Quality Control This duplex was sequence verified and functionally validated.
Storage Store at -20°C.
Components
1 vial of TYE 563 fluorescent-labeled transfection control siRNA duplex (1 nmol)
Stability The control is stable for one year from date of shipping when stored at -20°C.
Shipping Ambient
Note Single siRNA duplex (10nmol) can be ordered.
Reference Data
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

CASC15 dictates vascular smooth muscle cell growth fate and pathological vascular remodeling through post-transcription regulation of mitotic fidelity
Ahmed, Rajaganapathi, Rivero et al
bioRxiv (2026)
AI Summary: OriGene’s Trilencer-27 Fluorescent-labeled transfection control siRNA (SR30002) was used in this study to monitor and validate the efficiency of siRNA transfection in vascular smooth muscle cells.
Snippet: SR419361) and Trilencer-27 Fluorescentlabeled transfection control siRNA duplex (1 nmol;OriGene SR30002) were reconstituted with 100 uL and 50 uL ddH2O at 10 mM
Ivermectin B1a sensitizes TNBC cells to cyclophosphamide therapy in vitro by targeting PITRM1/SLC7A11-mediated ferroptotic pathway
Xu, Yang, Sheng et al
Letters in Drug Design & Discovery (2026)
AI Summary: OriGene's PITRM1 siRNA (si-PITRM1, #SR307158) and negative control siRNA (Scramble, #SR30002) were used to specifically knock down PITRM1 expression in TNBC cells, enabling the study of its role in cell proliferation, migration, and ferroptosis in this research.
Snippet: PITRM1 siRNA (si-PITRM1, #SR307158) and negative control siRNA (Scramble, #SR30002) were purchased from OriGene. Cells were transfected with 50 nM siRNA using Lipofectamine 3000, and harvested at 12–96 h for knockdown verification
Depletion of RBMS1 alleviates oxaliplatin chemoresistance in gastric cancer cells by suppressing the efflux function of ABCB1
Yang, Zhang, Chen et al
European Journal of Medical Research (2026)
AI Summary: OriGene products, including the RBMS1 human expression vector (SC319246), control vector (PS100020), RBMS1 Human siRNA Oligo Duplex (SR304012), EIF3D Human siRNA Oligo Duplex (SR305698), and control siRNA (SR30002), were used to modulate gene expression and investigate the role of RBMS1 and EIF3D in oxaliplatin chemoresistance in gastric cancer cells.
Snippet: The RBMS1 human expression vector (Cat. … SC319246) and the control vector (Cat. … PS100020) were purchased from OriGene (Rockville, MD, USA). RBMS1 Human siRNA Oligo Duplex (Cat. … SR304012), EIF3D Human siRNA Oligo Duplex (Cat. … SR305698) and the control siRNA (Cat. … SR30002) were purchased from OriGene (Rockville, MD, USA). …
Oxytocin regulation of intestinal stem cell self-renewal and differentiation
Liu, Guo, Geng et al
Cell Signal (2025) 139, 112337 DOI: 10.1016/j.cellsig.2025.112337
Cited by 2
AI Summary: OriGene products contributed to this study by providing the siTran 2.0 siRNA transfection reagent (TT320001), siRNA targeting Ptger4 (SR415743), and control siRNA (SR30002), which were used to investigate the role of EP4 in oxytocin-mediated intestinal stem cell regulation.
Snippet: Small interfering RNA (siRNA) transfections were carried out with siTran 2.0 siRNA transfection reagent (Origene, TT320001) according to the manufacturer's instructions. The organoids were transfected with siRNA Ptger4 (Origene, SR415743) or siRNA control (Origene, SR30002)
Loss of TET2 activity limits the ability of vitamin C to activate DNA demethylation in human HAP1 cells
Gawronski, Starczak, Wasilow et al
Epigenetics Chromatin (2025) 18 (1), 76 DOI: 10.1186/s13072-025-00634-1
Cited by 5
AI Summary: OriGene products, including anti-TET2 siRNA duplexes (cat. no. SR30002), Universal scrambled negative control siRNA duplex (cat. no. SR30004), and siTran 2.0 transfection reagent (cat. no. TT320001), were used to knock down TET2 expression and facilitate siRNA delivery in experiments investigating the role of TET2 in vitamin C-mediated DNA demethylation.
Snippet: mer anti-TET2 siRNA duplexes (cat. No.: SR30002), Universal scrambled negative control siRNA duplex (cat. no.: SR30004) as well as siTran 2.0 transfection reagent (cat. no. TT320001) were bought from OriGene. All siRNA experiments were conducted in accordance with manufacturers protocols. siRNA concentration, transfection time, and volume of transfection reagent were optimized before performing fi
FigureFigureFigure
TFAP2A induces cisplatin resistance via BNIP3-mediated mitophagy in non-small cell lung cancer
Guo, Yang, Jin et al
Transl Cancer Res (2025) 14 (9), 5353-5369 DOI: 10.21037/tcr-2025-646
Cited by 1
AI Summary: OriGene products contributed to this study by providing siRNAs targeting TFAP2A (SR304787) and a scrambled siRNA control (SR30002), which were used to investigate the role of TFAP2A in cisplatin resistance in non-small cell lung cancer cells.
Snippet: SiRNAs were purchased from OriGene to target TFAP2A (SR304787), a corresponding scrambled siRNA was used as a control (SR30002). The transfection was
FigureFigureFigure
Showing 1-6 of 32 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products